Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro‐in vivo correlation

Bioengineering & Translational Medicine

  ^{1    2    2    3} 

[1] Center for Bioengineering, University of California, Santa Barbara, Santa Barbara, CA 93106;Dept. of Chemical Engineering, University of California, Santa Barbara, Santa Barbara, CA 93106;John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138;John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138;

关键词: combination chemotherapy;    doxorubicin;    gemcitabine;    schedule;    synergy;   

DOI  :  10.1002/btm2.10082

来源: publisher

【 授权许可】

Unknown